NCT00747227 - Safety and Efficacy of a Violet Visible Light Blocking Intraocular Lens (IOL) | Biotech Hunter

Enrollment

250

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

June 30, 2009

Conditions

Cataract

Interventions

DEVICE

modified light transmission intraocular lens

violet visible light blocking acrylic intraocular lens

DEVICE

monofocal acrylic intraocular lens

conventional hydrophobic acrylic intraocular lens

Trial Locations (11)

William Christie, M.D., Cranberry Township

Mark Blecher, M.D., Philadelphia

Y. Ralph Chu, M.D., Bloomington

Vance Thompson, M.D., Sioux Falls

Steven Silverstein, M.D., Kansas City

Randall E. Cole, M.D., Rogers

Patrick Aiello, M.D., Scottsdale

Jon-Marc Weston, M.D., Roseburg

Jay Rudd, M.D., Lacey

Aron Rose, M.D., New Haven

Robert L. Bahr, M.D., Providence

All Listed Sponsors

lead

Abbott Medical Optics

INDUSTRY